OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Evan C. Chen, Jacqueline S. Garcia
Acta Haematologica (2023) Vol. 147, Iss. 2, pp. 198-218
Open Access | Times Cited: 6
Evan C. Chen, Jacqueline S. Garcia
Acta Haematologica (2023) Vol. 147, Iss. 2, pp. 198-218
Open Access | Times Cited: 6
Showing 6 citing articles:
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6356-6356
Open Access | Times Cited: 4
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6356-6356
Open Access | Times Cited: 4
Treatment of Relapsed/Refractory AML —Novel Treatment Options Including Immunotherapy
Catherine Gutierrez, Anthony S. Stein, Amir T. Fathi, et al.
American Journal of Hematology (2025) Vol. 100, Iss. S2, pp. 23-37
Closed Access
Catherine Gutierrez, Anthony S. Stein, Amir T. Fathi, et al.
American Journal of Hematology (2025) Vol. 100, Iss. S2, pp. 23-37
Closed Access
Therapy response in AML: a tale of two T cells
Livius Penter, Catherine J. Wu
Blood (2024) Vol. 144, Iss. 11, pp. 1134-1136
Closed Access | Times Cited: 2
Livius Penter, Catherine J. Wu
Blood (2024) Vol. 144, Iss. 11, pp. 1134-1136
Closed Access | Times Cited: 2
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
CD33 targeted EzH1 regulated nanotherapy epigenetically inhibits fusion oncoprotein (AML1-ETO) rearranged acute myeloid leukemia in both in vitro and in vivo Patient Derived Xenograft models
Avinash Chandra Kushwaha, Boddu Mrunalini, Dipanjan Ghosh, et al.
Nano Today (2024) Vol. 59, pp. 102542-102542
Closed Access
Avinash Chandra Kushwaha, Boddu Mrunalini, Dipanjan Ghosh, et al.
Nano Today (2024) Vol. 59, pp. 102542-102542
Closed Access
